'Failed policy': Doctors slam proposed PPI restrictions

Many patients with reflux will receive poorer care on low-dose drugs, they say

Repeat PPI scripts for gastro-oesphageal reflux disease should be restricted to the lowest doses unless the condition is confirmed by endoscopy, says the PBAC.


The restrictions are intended to curb long-term use of high-dose PPIs, which is associated with an increased risk of morbidity, according to PBAC proposals.

But GPs and gastroenterologists  have slammed the plan, saying it is unnecessary and a return to a “failed policy” of 24 years ago.

The proposed changes to the PBS follow advice from the PBAC’s Drug Utilisation Sub-Committee, which has